HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David R. Jones Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jones, D. R. Search for Related Content PubMed Articles by Jones, D. R. Related Collections Lung - cancer Molecular biology Related Article

Ann Thorac Surg 2001;71:1639
© 2001 The Society of Thoracic Surgeons

Invited commentary

^a Department of Thoracic and Cardiovascular Surgery, University of Virginia, PO Box 800679, Charlottesville, VA 22908-0679, USA

e-mail: djones@virginia.edu

While primary thoracic sarcomas are rare, their treatment remains difficult for the thoracic surgical oncologist. The primary treatment for thoracic sarcomas has gradually evolved into a multimodal approach, with many patients undergoing induction chemoradiotherapy followed by surgical resection with or without brachytherapy. Despite this aggressive approach, these tumors frequently have locoregional recurrence at the resection margins and may have distant metastasis as well.

Tumor angiogenesis is involved in both the . . . [Full Text of this Article]

Related Article

Expression of vascular endothelial growth factor in thoracic sarcomas

Akira Iyoda, Kenzo Hiroshima, Masayuki Baba, Takehiko Fujisawa, Toshikazu Yusa, and Hidemi Ohwada
Ann. Thorac. Surg. 2001 71: 1635-1639. [Abstract] [Full Text] [PDF]